FDA
approval
· 2022-12-21
FDA Approved: ARFORMOTEROL TARTRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
FDA approved Sun Pharmaceutical Industries' supplemental application for arformoterol tartrate, a generic inhaled long-acting beta-agonist used to treat chronic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ARFORMOTEROL TARTRATE (ARFORMOTEROL TARTRATE)